You have no items in your shopping cart.
Brevianamide F
SKU: orb1304423
Description
Research Area
Infectious Disease & Virology, Pharmacology & Drug Discovery, Signal Transduction
Images & Validation
−
Key Properties
−| CAS Number | 38136-70-8 |
|---|---|
| MW | 283.33 |
| Purity | 98.82% |
| Formula | C16H17N3O2 |
| SMILES | O=C1N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N2CCC[C@@H]12 |
| Target | PI3K,BCRP,Antibacterial |
| Solubility | 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.06 mM);DMSO:50 mg/mL (176.47 mM) |
Bioactivity
−| Target IC50 |
|---|
Storage & Handling
−| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
|---|---|
| Disclaimer | For research use only |
Alternative Names
−breast cancer resistance protein, Brevianamide F, Cyclo(L-Pro-L-Trp), cyclo-(L-Trp-L-Pro), Cyclo-L-tryptophyl-L-proline, antibacterial, Bacterial, inhibit, mycotoxin, Inhibitor, PI3Kα, PI3K, Phosphoinositide 3-kinase
Similar Products
−Brevianamide F [orb1225147]
>98% (HPLC)
38136-70-8
283.3
C16H17N3O2
1 g, 500 mg, 200 mg, 5 mg, 10 mg, 50 mg, 100 mg, 25 mg, 2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.
Documents Download
Datasheet
Product Information
Request a Document
Protocol Information
Brevianamide F (orb1304423)
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review